Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

Sanofi’s Subcutaneous Sarclisa Escena Approved in the US as First Anticancer Treatment Administered via On-Body Injector

Posted by GlobeNewswire on July 10, 2026

-------- Original Version -----------

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

-------- English Version ------------

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

-------- Link if available ----------

No Link available